Tumor Biology

, Volume 36, Issue 8, pp 5859–5864 | Cite as

Androgen receptor promotes esophageal cancer cell migration and proliferation via matrix metalloproteinase 2

  • Yi Zhang
  • Tiecheng Pan
  • Xiaoxuan Zhong
  • Cai Cheng
Research Article


Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide. Androgen receptor (AR) plays an important role in many kinds of cancers. However, the molecular mechanisms of AR in ESCC are poorly characterized. In the present study, Western blot analysis and real-time quantitative PCR were performed to identify differentially expressed AR in 40 ESCC tissue samples, which revealed that the messenger RNA (mRNA) and protein expression of AR is upregulated in the ESCC tissue samples. AR overexpression induced increases in ESCC cell invasion and proliferation in vitro. Silencing of AR inhibited the proliferation of KYSE450 cells which have a relatively high level of AR, and the invasion of KYSE450 cells was distinctly suppressed. Furthermore, AR knockdown led to substantial reductions in matrix metalloproteinase 2 (MMP2) and p-AKT levels in ESCC cell lines, but no significant change in AKT and MMP9 expression. These results suggest that AR is involved in tumor progression, and thus, AR could represent selective targets for the molecularly targeted treatments of ESCC.


Esophageal squamous cell carcinoma Androgen receptor Matrix metalloproteinases Small interfering RNA Proliferation Invasion Targeted therapy 



The study was funded by the grant “Experimental Study of the Splenic Artery Targeted Removal of Activated T Cells to Inhibit Acute Rejection”, 2012FFB03401, longitudinal support project by the Science and Technology Department of Hubei Province.

Conflicts of interest



  1. 1.
    Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–45.CrossRefPubMedGoogle Scholar
  2. 2.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMedGoogle Scholar
  3. 3.
    Chai J, Jamal MM. Esophageal malignancy: a growing concern. World J Gastroenterol. 2012;18:6521–6.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, et al. Predictors of progression in Barrett’s esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol. 2001;96:2839–48.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer. 2001;95:92–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Rosato A, Pivetta M, Parenti A, Iaderosa GA, Zoso A, et al. Survivin in esophageal cancer: an accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer. 2006;119:1717–22.CrossRefPubMedGoogle Scholar
  7. 7.
    Chen PJ, Yeh SH, Liu WH, Lin CC, Huang HC, Chen CL, et al. Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis. Hepatology. 2012;56(2):632–43.CrossRefPubMedGoogle Scholar
  8. 8.
    Ha S, Ruoff R, Kahoud N, Franke TF, Logan SK. Androgen receptor levels are upregulated by Akt in prostate cancer. Endocr Relat Cancer. 2011;18(2):245–55.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Ou Y, Liu L, Xue L, Zhou W, Zhao Z, Xu B, et al. TRAP1 shows clinical significance and promotes cellular migration and invasion through STAT3/MMP2 pathway in human esophageal squamous cell cancer. J Genet Genomics. 2014;41(10):529–37.CrossRefPubMedGoogle Scholar
  10. 10.
    Uraoka N, Oue N, Sakamoto N, Sentani K, Oo HZ, Naito Y, et al. NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression. Cancer Sci. 2014;105(1):134–40.CrossRefPubMedGoogle Scholar
  11. 11.
    Balk SP. Androgen receptor as a target in androgen-independent prostate cancer. Urology. 2002;60 Suppl 1:132–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Zhang BG, Du T, Zang MD, Chang Q, Fan ZY, Li JF, et al. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9. Oncotarget. 2014;5(21):10584–95.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr Relat Cancer. 2014;21(3):R165–82.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Slattery ML, Sweeney C, Murtaugh M, Ma KN, Caan BJ, Potter JD, et al. Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer. 2006;118(12):3140–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Yerramilli-Rao P, Garofalo O, Whatley S, Leigh PN, Gallo JM. Androgen-controlled specific gene expression in neuroblastoma cells. J Neurol Sci. 1995;129(Suppl):131–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Tihan T, Harmon JW, Wan X, Younes Z, Nass P, Duncan KL, et al. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res. 2001;21(4B):3107–14.PubMedGoogle Scholar
  17. 17.
    Yamashita Y, Hirai T, Mukaida H, Kawano K, Toge T, Niimoto M, et al. Detection of androgen receptors in human esophageal cancer. Jpn J Surg. 1989;19(2):195–202.CrossRefPubMedGoogle Scholar
  18. 18.
    Matsuoka H, Sugimachi K, Ueo H, Kuwano H, Nakano S, Nakayama M. Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res. 1987;47(15):4134–40.PubMedGoogle Scholar
  19. 19.
    Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25(1):9–34.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Yi Zhang
    • 1
  • Tiecheng Pan
    • 2
  • Xiaoxuan Zhong
    • 1
    • 2
  • Cai Cheng
    • 2
  1. 1.Department of SurgeryThe Third Affiliated Hospital of Jianghan UniversityWuhanChina
  2. 2.Division of Cardiothoracic Surgery, Tongji Hospital of Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations